Empresas y finanzas

Asterand Offers Researchers Internet Access to RNA to Speed Drug Discovery



    Asterand (LSE:ATD), the Detroit based biobanking company is
    offering research scientists simple and easy access to human RNA
    samples via the internet.

    "This is a valuable new service to help scientists focused on
    early stage drug discovery," says Dr Victoria Blanc Asterand's
    Director of Product Development. "The first RNA samples available
    through Asterand's e-commerce site (http://solutions.asterand.com)
    include those from common cancers such as breast and colon cancer.
    Over time we will be adding thousands of RNA samples from a wide range
    of diseases."

    "The value of RNA analysis is that it is an effective way of
    differentiating between the diseased state and normal state of
    tissues. Our provision of this material over the internet expedites
    the process of identification of novel cellular targets for drug
    development.

    "The high quality RNA coupled with the ease of acquisition is
    important because the isolation of the RNA is complete, the RNA
    integrity has been evaluated and approved, and therefore experiments
    can be planned and executed without delays."

    "We are providing scientists with unique and unusual material.
    Each sample of total RNA is from an individual donor, supplied in 5 ug
    aliquots. Asterand standard clinical data are provided with every
    sample, along with pathology report details, so that the clinical
    context of the RNA can be understood. Each sample has been quality
    assured by use of the Agilent Bioanalyzer and confirmed to have an RNA
    integrity number of at least 6, and in tumor samples, no less than 70%
    tumor cells. This ensures that the materials are suitable for all
    forms of gene expression analysis - from Northern blots, to TaqMan to
    Affymetrix chips.

    "Over the last several years we have gained a great deal of
    experience in processing hundreds of thousands of samples of RNA,"
    says Dr Anja Penger, Director of Biomaterials, and head of the RNA
    project at Asterand's UK facility in Royston, UK. "Our team has high
    throughput capacity for measuring and aliquotting samples, bar-coding
    and distribution. We are very excited to be able to provide the RNA
    with the efficiency of online sales."

    Asterand plc is a UK public company that supports human drug
    discovery by providing high quality, well characterised human
    biomaterials and preclinical research services.